vs

Side-by-side financial comparison of Innovex International, Inc. (INVX) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.

Innovex International, Inc. is the larger business by last-quarter revenue ($273.6M vs $221.4M, roughly 1.2× UNIVERSAL TECHNICAL INSTITUTE INC). Innovex International, Inc. runs the higher net margin — 5.1% vs 0.2%, a 4.9% gap on every dollar of revenue. On growth, Innovex International, Inc. posted the faster year-over-year revenue change (9.1% vs 6.7%). Over the past eight quarters, Innovex International, Inc.'s revenue compounded faster (46.2% CAGR vs 11.7%).

INVX vs UTI — Head-to-Head

Bigger by revenue
INVX
INVX
1.2× larger
INVX
$273.6M
$221.4M
UTI
Growing faster (revenue YoY)
INVX
INVX
+2.4% gap
INVX
9.1%
6.7%
UTI
Higher net margin
INVX
INVX
4.9% more per $
INVX
5.1%
0.2%
UTI
Faster 2-yr revenue CAGR
INVX
INVX
Annualised
INVX
46.2%
11.7%
UTI

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
INVX
INVX
UTI
UTI
Revenue
$273.6M
$221.4M
Net Profit
$14.0M
$433.0K
Gross Margin
28.9%
Operating Margin
9.4%
0.2%
Net Margin
5.1%
0.2%
Revenue YoY
9.1%
6.7%
Net Profit YoY
-56.1%
-60.5%
EPS (diluted)
$0.20
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INVX
INVX
UTI
UTI
Q1 26
$221.4M
Q4 25
$273.6M
$220.8M
Q3 25
$240.0M
$222.4M
Q2 25
$224.2M
$204.3M
Q1 25
$240.4M
$207.4M
Q4 24
$250.7M
$201.4M
Q3 24
$151.8M
$196.4M
Q2 24
$130.3M
$177.5M
Net Profit
INVX
INVX
UTI
UTI
Q1 26
$433.0K
Q4 25
$14.0M
$12.8M
Q3 25
$39.2M
$18.8M
Q2 25
$15.3M
$10.7M
Q1 25
$14.8M
$11.4M
Q4 24
$31.8M
$22.2M
Q3 24
$82.6M
$18.8M
Q2 24
$9.5M
$5.0M
Gross Margin
INVX
INVX
UTI
UTI
Q1 26
Q4 25
28.9%
Q3 25
31.6%
Q2 25
32.0%
Q1 25
31.8%
Q4 24
33.9%
Q3 24
34.7%
Q2 24
35.3%
Operating Margin
INVX
INVX
UTI
UTI
Q1 26
0.2%
Q4 25
9.4%
7.1%
Q3 25
26.0%
11.2%
Q2 25
10.1%
6.9%
Q1 25
9.1%
8.1%
Q4 24
10.7%
13.6%
Q3 24
-8.7%
13.3%
Q2 24
10.0%
4.2%
Net Margin
INVX
INVX
UTI
UTI
Q1 26
0.2%
Q4 25
5.1%
5.8%
Q3 25
16.3%
8.4%
Q2 25
6.8%
5.2%
Q1 25
6.1%
5.5%
Q4 24
12.7%
11.0%
Q3 24
54.4%
9.6%
Q2 24
7.3%
2.8%
EPS (diluted)
INVX
INVX
UTI
UTI
Q1 26
$0.01
Q4 25
$0.20
$0.23
Q3 25
$0.57
$0.33
Q2 25
$0.22
$0.19
Q1 25
$0.21
$0.21
Q4 24
$-0.03
$0.40
Q3 24
$1.99
$0.35
Q2 24
$0.30
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INVX
INVX
UTI
UTI
Cash + ST InvestmentsLiquidity on hand
$162.0M
Total DebtLower is stronger
$18.9M
$127.8M
Stockholders' EquityBook value
$1.1B
$339.9M
Total Assets
$1.3B
$852.2M
Debt / EquityLower = less leverage
0.02×
0.38×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INVX
INVX
UTI
UTI
Q1 26
$162.0M
Q4 25
$162.8M
Q3 25
$169.1M
Q2 25
$70.7M
Q1 25
$96.0M
Q4 24
$172.0M
Q3 24
$161.9M
Q2 24
$185.6M
$115.5M
Total Debt
INVX
INVX
UTI
UTI
Q1 26
$127.8M
Q4 25
$18.9M
$101.4M
Q3 25
$20.1M
$87.1M
Q2 25
$34.8M
$73.8M
Q1 25
$19.7M
$94.4M
Q4 24
$24.9M
$120.1M
Q3 24
$12.4M
$125.7M
Q2 24
$137.3M
Stockholders' Equity
INVX
INVX
UTI
UTI
Q1 26
$339.9M
Q4 25
$1.1B
$335.9M
Q3 25
$1.0B
$328.1M
Q2 25
$995.6M
$306.8M
Q1 25
$978.4M
$293.9M
Q4 24
$958.2M
$280.0M
Q3 24
$904.4M
$260.2M
Q2 24
$352.5M
$239.4M
Total Assets
INVX
INVX
UTI
UTI
Q1 26
$852.2M
Q4 25
$1.3B
$834.0M
Q3 25
$1.3B
$826.1M
Q2 25
$1.2B
$740.8M
Q1 25
$1.2B
$720.4M
Q4 24
$1.2B
$753.8M
Q3 24
$1.1B
$744.6M
Q2 24
$1.0B
$706.0M
Debt / Equity
INVX
INVX
UTI
UTI
Q1 26
0.38×
Q4 25
0.02×
0.30×
Q3 25
0.02×
0.27×
Q2 25
0.03×
0.24×
Q1 25
0.02×
0.32×
Q4 24
0.03×
0.43×
Q3 24
0.01×
0.48×
Q2 24
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INVX
INVX
UTI
UTI
Operating Cash FlowLast quarter
$52.2M
$7.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.74×
16.33×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INVX
INVX
UTI
UTI
Q1 26
$7.1M
Q4 25
$52.2M
$3.1M
Q3 25
$48.4M
$57.1M
Q2 25
$59.2M
$18.1M
Q1 25
$31.1M
$-789.0K
Q4 24
$36.3M
$23.0M
Q3 24
$21.7M
$67.5M
Q2 24
$22.8M
$10.0M
Free Cash Flow
INVX
INVX
UTI
UTI
Q1 26
Q4 25
$-19.2M
Q3 25
$40.6M
Q2 25
$6.8M
Q1 25
$-11.7M
Q4 24
$19.6M
Q3 24
$60.0M
Q2 24
$16.6M
$3.0M
FCF Margin
INVX
INVX
UTI
UTI
Q1 26
Q4 25
-8.7%
Q3 25
18.3%
Q2 25
3.4%
Q1 25
-5.7%
Q4 24
9.7%
Q3 24
30.6%
Q2 24
12.7%
1.7%
Capex Intensity
INVX
INVX
UTI
UTI
Q1 26
Q4 25
10.1%
Q3 25
7.4%
Q2 25
5.5%
Q1 25
5.3%
Q4 24
1.7%
Q3 24
3.8%
Q2 24
4.7%
4.0%
Cash Conversion
INVX
INVX
UTI
UTI
Q1 26
16.33×
Q4 25
3.74×
0.24×
Q3 25
1.23×
3.04×
Q2 25
3.86×
1.69×
Q1 25
2.11×
-0.07×
Q4 24
1.14×
1.04×
Q3 24
0.26×
3.58×
Q2 24
2.39×
2.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INVX
INVX

Products$202.7M74%
Leasing$42.3M15%
Services$28.6M10%

UTI
UTI

Segment breakdown not available.

Related Comparisons